MicroRNAs as potential biomarkers of smoking-related diseases

Biomarkers in Medicine

Volumn 6, Issue 5, 2012, Pages 671-684

  Banerjee, Anisha ^a   Luettich, Karsta ^a  

^a BRITISH AMERICAN TOBACCO   (United Kingdom)

Author keywords

biomarker; cancer; cardiovascular disease; chronic obstructive pulmonary disease; inflammation; miRNA; smoking

Indexed keywords

ACETYLCYSTEINE; BUDESONIDE; CIGARETTE SMOKE; LET 7 MICRORNA; MICRORNA; MICRORNA 155; MICRORNA 15A; MICRORNA 16; MICRORNA 21; MICRORNA 221; MICRORNA 222; MICRORNA 34A; PHENETHYL ISOTHIOCYANATE; PROTEIN P53; TRANSCRIPTION FACTOR ZEB1; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANGIOGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHEMICAL CARCINOGENESIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CPG ISLAND; DNA ADDUCT; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION PROFILING; HUMAN; INFLAMMATION; LUNG CANCER; LUNG CARCINOGENESIS; METASTASIS; NONHUMAN; ONCOGENE; ONCOGENE MYC; PULMONARY HYPERTENSION; REVIEW; RISK FACTOR; SMOKING; TUMOR SUPPRESSOR GENE;

ANIMALS; DISEASE; GENETIC MARKERS; HUMANS; INFLAMMATION; MICRORNAS; SMOKING;

EID: 84867635564     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.12.50     Document Type: Review

References (97)

1. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75(5), 843-854 (1993). (Pubitemid 24014542)
2. Pasquinelli AE, Reinhart BJ, Slack F et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408(6808), 86-89 (2000).
3. Wang Z, Luo X, Lu Y, Yang B. miRNAs at the heart of the matter. J. Mol. Med. 86(7), 771-783 (2008).
4. George GP, Mittal RD. MicroRNAs: potential biomarkers in cancer. Ind. J. Clin. Biochem. 25, 4-14 (2010).
5. Kloosterman W P, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev. Cell 11(4), 441-450 (2006). (Pubitemid 44430905)
6. Nana-Sinkam SP, Karsies T, Riscili B, Ezzie M, Piper M. Lung microRNA: from development to disease. Expert Rev. Respir. Med. 3(4), 373-385 (2009).
7. Stahlhut Espinosa CE, Slack FJ. The role of microRNAs in cancer. Yale J. Biol. Med. 79(3-4), 131-140 (2006).
8. Bartels CL, Tsongalis GJ. MicroRNAs: novel biomarkers for human cancer. Clin. Chem. 55(4), 623-631 (2009).
9. Griffths-Jones S, Grocock RJ, van DS, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 34(Database issue), D140-D144 (2006).
10. Lema C, Cunningham MJ. MicroRNAs and their implications in toxicological research. Toxicol. Lett. 198(2), 100-105 (2010).
11. Chen T. The role of MicroRNA in chemical carcinogenesis. J. Environ. Sci. Health C. Environ. Carcinog. Ecotoxicol. Rev. 28(2), 89-124 (2010).
12. Howard G, Wagenknecht LE, Burke GL et al. Cigarette smoking and progression of atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. JAMA 279(2), 119-124 (1998). (Pubitemid 28068301)
13. Koturbash I, Zemp FJ, Pogribny I, Kovalchuk O. Small molecules with big effects: the role of the microRNAome in cancer and carcinogenesis. Mutat. Res. 722(2), 94-105 (2011).
14. Chang TC, Wentzel EA, Kent OA et al. Transactivation of miR-34a by p53 broadly infuences gene expression and promotes apoptosis. Mol. Cell 26(5), 745-752 (2007). (Pubitemid 46856245)
15. Lujambio A, Ropero S, Ballestar E et al. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res. 67(4), 1424-1429 (2007). (Pubitemid 46383366)
16. Melo SA, Ropero S, Moutinho C et al. A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat. Genet. 41(3), 365-370 (2009).
17. Saito Y, Liang G, Egger G et al. Specifc activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9(6), 435-443 (2006). (Pubitemid 43832188)
18. Thomson JM, Newman M, Parker JS, Morin-Kensicki EM, Wright T, Hammond SM. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev. 20(16), 2202-2207 (2006).
19. Sevignani C, Calin GA, Nnadi SC et al. MicroRNA genes are frequently located near mouse cancer susceptibility loci. Proc. Natl Acad. Sci. USA 104(19), 8017-8022 (2007). (Pubitemid 47185868)
20. Melo SA, Esteller M. Dysregulation of microRNAs in cancer: playing with fre. FEBS Lett. 585(13), 2087-2099 (2010).
21. Calin GA, Dumitru CD, Shimizu M et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA 99(24), 15524-15529 (2002). (Pubitemid 35403967)
22. Costinean S, Zanesi N, Pekarsky Y et al. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc. Natl Acad. Sci. USA 103(18), 7024-7029 (2006).
23. Klein U, Lia M, Crespo M et al. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 17(1), 28-40 (2010).
24. Hudder A, Novak RF. miRNAs: effectors of environmental infuences on gene expression and disease. Toxicol. Sci. 103(2), 228-240 (2008). (Pubitemid 351659596)
25. Iorio MV, Ferracin M, Liu CG et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65(16), 7065-7070 (2005). (Pubitemid 41161233)
26. Lu J, Getz G, Miska EA et al. MicroRNA expression profles classify human cancers. Nature 435(7043), 834-838 (2005). (Pubitemid 40839735)
27. Gaur A, Jewell DA, Liang Y et al. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res. 67(6), 2456-2468 (2007). (Pubitemid 46548930)
28. Yanaihara N, Caplen N, Bowman E et al. Unique microRNA molecular profles in lung cancer diagnosis and prognosis. Cancer Cell 9(3), 189-198 (2006). (Pubitemid 43357945)
29. Shen YL, Jiang YG, Greenlee AR, Zhou LL, Liu LH. MicroRNA expression profles and miR-10a target in anti-benzo[a] pyrene-7, 8-diol-9, 10-epoxide-transformed human 16HBE cells. Biomed. Environ. Sci. 22(1), 14-21 (2009).
30. Pogribny IP, Tryndyak VP, Boyko A, Rodriguez-Juarez R, Beland FA, Kovalchuk O. Induction of microRNAome deregulation in rat liver by long-term tamoxifen exposure. Mutat. Res. 619(1-2), 30-37 (2007). (Pubitemid 46602445)
31. Hayashita Y, Osada H, Tatematsu Y et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 65(21), 9628-9632 (2005). (Pubitemid 41541436)
32. Ruan K, Fang X, Ouyang G. MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett. 285(2), 116-126 (2009).
33. Asangani IA, Rasheed SA, Nikolova DA et al. MicroRNA-21 (miR-21) post- transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27(15), 2128-2136 (2008). (Pubitemid 351485639)
34. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133(2), 647-658 (2007). (Pubitemid 47187346)
35. Vandenboom Ii TG, Li Y, Philip PA, Sarkar FH. MicroRNA and cancer: tiny molecules with major implications. Curr. Genomics 9(2), 97-109 (2008). (Pubitemid 351888527)
36. Takamizawa J, Konishi H, Yanagisawa K et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 64(11), 3753-3756 (2004). (Pubitemid 38697282)
37. Wu F, Zhu S, Ding Y, Beck WT, Mo YY MicroRNA-mediated regulation of Ubc9 expression in cancer cells. Clin. Cancer Res. 15(5), 1550-1557 (2009).
38. Geiss-Friedlander R, Melchior F. Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell. Biol. 8(12), 947-956 (2007). (Pubitemid 350176509)
39. Bueno MJ, Malumbres M. MicroRNAs and the cell cycle. Biochim. Biophys. Acta 1812(5), 592-601 (2011).
40. Inui M, Martello G, Piccolo S. MicroRNA control of signal transduction. Nat. Rev. Mol. Cell. Biol. 11(4), 252-263 (2010).
41. Kong W, Yang H, He L et al. MicroRNA-155 is regulated by the transforming growth factor b/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol. Cell. Biol. 28(22), 6773-6784 (2008).
42. Xu J, Kochanek KD, Murphy SL, Tejada- Vera B. Deaths: Final data for 2007. Natl Vital Stat. Rep. 58, 1-135 (2010).
43. Murray CJL. The Global Burden of Disease. World Health Organization, Geneva, Switzerland; Harvard School of Public Health, Boston, MA; World Bank (1996).
44. Oglesby IK, McElvaney NG, Greene CM. MicroRNAs in infammatory lung disease - master regulators or target practice? Respir. Res. 11, 148 (2010).
45. Sato T, Liu X, Nelson A et al. Reduced miR-146a increases prostaglandin Ein chronic obstructive pulmonary disease fbroblasts. Am. J. Respir. Crit. Care Med. 182(8), 1020-1029 (2010).
46. Pottelberge GR, Mestdagh P, Bracke KR et al. MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 183(7), 898-906 (2011).
47. Akbas F, Coskunpinar E, Aynaci E, Musteri OY, Yildiz P. Analysis of serum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease. Exp. Lung Res. 38(6), 286-294 (2012).
48. Izzotti A, Calin GA, Steele VE, Croce CM, De FS. Relationships of microRNA expression in mouse lung with age and exposure to cigarette smoke and light. FASEB J. 23(9), 3243-3250 (2009).
49. Schroen B, Heymans S. MicroRNAs and beyond: the heart reveals its treasures. Hypertension 54(6), 1189-1194 (2009).
50. Catalucci D, Gallo P, Condorelli G. MicroRNAs in cardiovascular biology and heart disease. Circ. Cardiovasc. Genet. 2(4), 402-408 (2009).
51. Sen CK, Gordillo GM, Khanna S, Roy S. Micromanaging vascular biology: tiny microRNAs play big band. J. Vasc. Res. 46(6), 527-540 (2009).
52. Haver VG, Slart RH, Zeebregts CJ, Peppelenbosch M P, Tio RA. Rupture of vulnerable atherosclerotic plaques: microRNAs conducting the orchestra? Trends Cardiovasc. Med. 20(2), 65-71 (2010).
53. Urbich C, Kuehbacher A, Dimmeler S. Role of microRNAs in vascular diseases, infammation, and angiogenesis. Cardiovasc. Res. 79(4), 581-588 (2008).
54. Harris TA, Yamakuchi M, Ferlito M, Mendell JT, Lowenstein CJ. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc. Natl Acad. Sci. USA 105(5), 1516-1521 (2008). (Pubitemid 351346546)
55. Ji R, Cheng Y, Yue J et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ. Res. 100(11), 1579-1588 (2007). (Pubitemid 46897261)
56. Martin MM, Buckenberger JA, Jiang J et al. The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microrna-155 binding. J. Biol. Chem. 282(33), 24262-24269 (2007). (Pubitemid 47328062)
57. O'Connell RM, Rao DS, Chaudhuri AA et al. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J. Exp. Med. 205(3), 585-594 (2008). (Pubitemid 351439306)
58. Pasterkamp G, Van Keulen JK, de Kleijn DP. Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease. Eur. J. Clin. Invest 34(5), 328-334 (2004). (Pubitemid 38748072)
59. Chen XM, Splinter PL, O'Hara SP, LaRusso NF. A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection. J. Biol. Chem. 282(39), 28929-28938 (2007). (Pubitemid 47610421)
60. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl Acad. Sci. USA 103(33), 12481-12486 (2006). (Pubitemid 44267285)
61. Small EM, Frost RJ, Olson EN. MicroRNAs add a new dimension to cardiovascular disease. Circulation 121(8), 1022-1032 (2010).
62. Yang WJ, Yang DD, Na S, Sandusky GE, Zhang Q, Zhao G. Dicer is required for embryonic angiogenesis during mouse development. J. Biol. Chem. 280(10), 9330-9335 (2005). (Pubitemid 40409626)
63. Kuehbacher A, Urbich C, Zeiher AM, Dimmeler S. Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ. Res. 101(1), 59-68 (2007). (Pubitemid 47094624)
64. Bonauer A, Carmona G, Iwasaki M et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324(5935), 1710-1713 (2009).
65. Chico TJ, Milo M, Crossman DC. The genetics of cardiovascular disease: new insights from emerging approaches. J. Pathol. 220(2), 186-197 (2010).
66. Poliseno L, Tuccoli A, Mariani L et al. MicroRNAs modulate the angiogenic properties of HUVECs. Blood 108(9), 3068-3071 (2006).
67. Tuccoli A, Poliseno L, Rainaldi G. miRNAs regulate miRNAs: coordinated transcriptional and post-transcriptional regulation. Cell Cycle 5(21), 2473-2476 (2006). (Pubitemid 44785824)
68. Suarez Y, Fernandez-Hernando C, Pober JS, Sessa WC. Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ. Res. 100(8), 1164-1173 (2007). (Pubitemid 46684129)
69. Cordes KR, Srivastava D. MicroRNA regulation of cardiovascular development. Circ. Res. 104(6), 724-732 (2009).
70. Fasanaro P, Greco S, Lorenzi M et al. An integrated approach for experimental target identifcation of hypoxia-induced miR-210. J. Biol. Chem. 284(50), 35134-35143 (2009).
71. Simonneau G, Robbins IM, Beghetti M et al. Updated clinical classifcation of pulmonary hypertension. J. Am. Coll. Cardiol. 54(Suppl. 1), S43-S54 (2009).
72. McGoon M, Gutterman D, Steen V et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126(Suppl. 1), S14-S34 (2004).
73. Caruso P, MacLean MR, Khanin R et al. Dynamic changes in lung microRNA profles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline. Arterioscler. Thromb. Vasc. Biol. 30(4), 716-723 (2010).
74. Courboulin A, Paulin R, Giguere NJ et al. Role for miR-204 in human pulmonary arterial hypertension. J. Exp. Med. 208(3), 535-548 (2011).
75. Tsitsiou E, Lindsay MA. MicroRNAs and the immune response. Curr. Opin. Pharmacol. 9(4), 514-520 (2009).
76. Sonkoly E, Stahle M, Pivarcsi A. MicroRNAs and immunity: novel players in the regulation of normal immune function and infammation. Semin. Cancer Biol. 18(2), 131-140 (2008).
77. Perry MM, Moschos SA, Williams AE, Shepherd NJ, Larner-Svensson HM, Lindsay MA. Rapid changes in microRNA-146a expression negatively regulate the IL-1beta- induced infammatory response in human lung alveolar epithelial cells. J. Immunol. 180(8), 5689-5698 (2008).
78. Izzotti A, Calin GA, Arrigo P, Steele VE, Croce CM, De Flora S. Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J. 23 (3), 806-812 (2009).
79. Spira A, Beane J, Shah V et al. Effects of cigarette smoke on the human airway epithelial cell transcriptome. Proc. Natl Acad. Sci. USA 101(27), 10143-10148 (2004). (Pubitemid 38891209)
80. Kalscheuer S, Zhang X, Zeng Y, Upadhyaya P. Differential expression of microRNAs in early-stage neoplastic transformation in the lungs of F344 rats chronically treated with the tobacco carcinogen 4-(methylnitrosamino)-1-(3- pyridyl)-1- butanone. Carcinogenesis 29(12), 2394-2399 (2008).
81. Izzotti A, Larghero P, Cartiglia C et al. Modulation of microRNA expression by budesonide, phenethyl isothiocyanate and cigarette smoke in mouse liver and lung. Carcinogenesis 31(5), 894-901 (2010).
82. Izzotti A, Larghero P, Balansky R, Pfeffer U, Steele VE, De FS. Interplay between histopathological alterations, cigarette smoke and chemopreventive agents in defning microRNA profles in mouse lung. Mutat. Res. 717(1-2), 17-24 (2011).
83. Izzotti A, Larghero P, Longobardi M et al. Dose-responsiveness and persistence of microRNA expression alterations induced by cigarette smoke in mouse lung. Mutat. Res. 717(1-2), 9-16 (2011).
84. Russ R, Slack FJ. Cigarette-smoke-induced dysregulation of microRNA expression and its role in lung carcinogenesis. Pulm. Med. 2012, 791234 (2012).
85. Schembri F, Sridhar S, Perdomo C et al. MicroRNAs as modulators of smoking- induced gene expression changes in human airway epithelium. Proc. Natl Acad. Sci. USA 106(7), 2319-2324 (2009).
86. Christenson SA, Schembri FM, Sridhar S et al. Impact of smoking on miRNA expression in buccal and nasal epithelium. Am. J. Respir. Crit. Care Med. (179), 457-466 (2009).
87. Swan GE, Hodgkin JE, Roby T, Mittman C, Jacobo N, Peters J. Reversibility of airways injury over a 12-month period following smoking cessation. Chest 101(3), 607-612 (1992).
88. Moriyama C, Betsuyaku T, Nishimura M. Effects of aging and smoking on MicroRNA expression profling in bronchiolar epithelium. Am. J. Respir. Crit. Care Med. 181, A2025 (2010).
89. Perdomo C, Spira A, Schembri F. MiRNAs as regulators of the response to inhaled environmental toxins and airway carcinogenesis. Mutat. Res. 717(1-2), 32-37 (2011).
90. Jardim MJ, Fry RC, Jaspers I, Dailey L, Diaz-Sanchez D. Disruption of microRNA expression in human airway cells by diesel exhaust particles is linked to tumorigenesis- associated pathways. Environ. Health P er spect. 117(11), 1745-1751 (2009).
91. Biomarkers Defnition Working Group. Biomarkers and surrogate endpoints: preferred defnitions and conceptual framework. Clin. Pharmacol. Ther. 69(3), 89-95 (2001).
92. Waldman SA, Terzic A. Translating MicroRNA discovery into clinical biomarkers in cancer. JAMA 297(17), 1923-1925 (2007). (Pubitemid 46707848)
93. Mascaux C, Laes JF, Anthoine G et al. Evolution of microRNA expression during human bronchial squamous carcinogenesis. Eur. Respir. J. 33(2), 352-359 (2009).
94. Rabinowits G, Gercel-Taylor C, Day JM, Taylor DD, Kloecker GH. Exosomal microRNA: a diagnostic marker for lung cancer. Clin. Lung Cancer 10(1), 42-46 (2009).
95. Weber JA, Baxter DH, Zhang S et al. The microRNA spectrum in 12 body fuids. Clin. Chem. 56(11), 1733-1741 (2010).
96. Small EM, Olson EN. Pervasive roles of microRNAs in cardiovascular biology. Nature 469(7330), 336-342 (2011).
97. Fish JE, Santoro MM, Morton SU et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev. Cell 15(2), 272-284 (2008).